Another study revealed that YAP controls the expression of p62 in lung adenocarcinoma, and the YAP inhibitor verteporfin suppresses YAP, p62, and PD-L1 simultaneously [15]. This evidence concerns the gene YAP1 and lung adenocarcinoma.